Asante Bio

Executive Summary

Asante Bio is a private joint preservation company developing regenerative orthobiologic implants that combine innovative biomaterials and biomanufacturing technologies. Founded in 2018 and based in Cambridge, MA, the company focuses on creating biomechanical, load-sharing orthopedic devices to address unmet needs in orthopedics and sports medicine. By integrating surgeon experience, biology, and biomechanics, Asante Bio aims to provide solutions that preserve joint function and delay or prevent the need for joint replacement. The company operates in the early-stage private sector with no disclosed funding or valuation, but its proprietary platform and focus on the growing orthobiologics market position it for potential growth as it advances its product pipeline.

Upcoming Catalysts (preview)

• Q3 2026Series A funding round50% success
• Q4 2026First-in-human clinical trial initiation30% success
• TBDFDA breakthrough device designation20% success